China Resources Sanjiu Medical & Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
China Resources Sanjiu Medical & Pharmaceutical has a total shareholder equity of CN¥25.7B and total debt of CN¥2.9B, which brings its debt-to-equity ratio to 11.3%. Its total assets and total liabilities are CN¥41.2B and CN¥15.5B respectively. China Resources Sanjiu Medical & Pharmaceutical's EBIT is CN¥3.8B making its interest coverage ratio -59.5. It has cash and short-term investments of CN¥8.8B.
Key information
11.3%
Debt to equity ratio
CN¥2.92b
Debt
| Interest coverage ratio | -59.5x |
| Cash | CN¥8.83b |
| Equity | CN¥25.73b |
| Total liabilities | CN¥15.52b |
| Total assets | CN¥41.25b |
Recent financial health updates
No updates
Recent updates
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Apr 23
An Intrinsic Calculation For China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Suggests It's 50% Undervalued
Apr 16Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Mar 20Do China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Earnings Warrant Your Attention?
Feb 28Financial Position Analysis
Short Term Liabilities: 000999's short term assets (CN¥23.7B) exceed its short term liabilities (CN¥12.6B).
Long Term Liabilities: 000999's short term assets (CN¥23.7B) exceed its long term liabilities (CN¥2.9B).
Debt to Equity History and Analysis
Debt Level: 000999 has more cash than its total debt.
Reducing Debt: 000999's debt to equity ratio has increased from 0.3% to 11.3% over the past 5 years.
Debt Coverage: 000999's debt is well covered by operating cash flow (160.2%).
Interest Coverage: 000999 earns more interest than it pays, so coverage of interest payments is not a concern.